# B2B Referral Engine - Daily Prospects
**Date:** Tuesday, February 24th, 2026
**Generated:** 9:17 AM EST

---

## Summary
- **Total Prospects:** 14
- **High Priority (80+):** 4
- **Medium Priority (60-79):** 6
- **Potential Fees:** $46,000 - $87,500

---

## HIGH PRIORITY PROSPECTS (Score 80+)

### 1. Fundamental — Score: 92/100
| Attribute | Details |
|-----------|---------|
| **Company** | Fundamental (AI Research) |
| **Vertical** | Technology/SaaS |
| **Funding** | $255M Series A (Feb 5, 2026) |
| **Location** | US |
| **Buying Signals** | Massive Series A, AI research focus, rapid expansion phase |
| **Fee Potential** | $5K + 10-20% ACV (Tech/SaaS) |
| **Score Breakdown** | Intent: 38/40, Vertical: 28/30, Size: 18/20, Specificity: 8/10 |
| **Referral Target** | Legal (corporate structure), Accounting (scale), SaaS implementations |
| **Contact Priority** | Immediate - fresh funding, actively hiring |

---

### 2. Uptiq — Score: 88/100
| Attribute | Details |
|-----------|---------|
| **Company** | Uptiq |
| **Vertical** | Financial Services B2B |
| **Funding** | $25M Series B (Feb 2026) |
| **Location** | Dallas, TX |
| **Buying Signals** | Series B scaling, AI financial services, B2B infrastructure |
| **Fee Potential** | $2.5K (Financial Services) |
| **Score Breakdown** | Intent: 36/40, Vertical: 26/30, Size: 18/20, Specificity: 8/10 |
| **Referral Target** | Treasury services, lending partnerships, compliance consulting |
| **Contact Priority** | High - scaling financial services needs vendor network |

---

### 3. Synthpop — Score: 86/100
| Attribute | Details |
|-----------|---------|
| **Company** | Synthpop, Inc. |
| **Vertical** | Technology/SaaS (Healthcare AI) |
| **Funding** | $15M Series A (Feb 2026) |
| **Location** | Cambridge, MA |
| **Buying Signals** | Series A, healthcare AI expansion, multi-agent platform |
| **Fee Potential** | $5K + 10-20% ACV |
| **Score Breakdown** | Intent: 35/40, Vertical: 27/30, Size: 16/20, Specificity: 8/10 |
| **Referral Target** | Legal (HIPAA compliance), Accounting (healthcare), SaaS integrations |
| **Contact Priority** | High - healthcare compliance needs are critical |

---

### 4. Take2 — Score: 82/100
| Attribute | Details |
|-----------|---------|
| **Company** | Take2 |
| **Vertical** | Technology/SaaS (Healthcare Recruiting AI) |
| **Funding** | $14M Series A (Feb 2026) |
| **Location** | US |
| **Buying Signals** | Series A, AI recruiting automation, healthcare focus |
| **Fee Potential** | $5K + 10-20% ACV |
| **Score Breakdown** | Intent: 34/40, Vertical: 26/30, Size: 16/20, Specificity: 6/10 |
| **Referral Target** | HR consulting, legal (employment), accounting (payroll scale) |
| **Contact Priority** | High - hiring platforms need compliance infrastructure |

---

## MEDIUM PRIORITY PROSPECTS (Score 60-79)

### 5. ShowroomB2B — Score: 78/100
| Attribute | Details |
|-----------|---------|
| **Company** | ShowroomB2B |
| **Vertical** | Manufacturing/Supply Chain |
| **Funding** | $17M Series A (Feb 2026) |
| **Location** | India/Global |
| **Lead Investor** | Cactus Partners |
| **Buying Signals** | Series A, B2B apparel platform, supply chain focus |
| **Fee Potential** | $1K (Manufacturing) |
| **Score Breakdown** | Intent: 32/40, Vertical: 22/30, Size: 16/20, Specificity: 8/10 |
| **Referral Target** | Supply chain consultants, logistics, manufacturing accounting |

---

### 6. Circadian Risk — Score: 75/100
| Attribute | Details |
|-----------|---------|
| **Company** | Circadian Risk |
| **Vertical** | Technology/SaaS (Security) |
| **Funding** | $6M Series A (Oversubscribed, Feb 2026) |
| **Location** | Ann Arbor, MI |
| **Buying Signals** | Oversubscribed round, enterprise risk assessment, scaling |
| **Fee Potential** | $5K + 10-20% ACV |
| **Score Breakdown** | Intent: 30/40, Vertical: 25/30, Size: 14/20, Specificity: 6/10 |
| **Referral Target** | Cybersecurity compliance, legal (enterprise contracts), accounting |

---

### 7. Altesa — Score: 72/100
| Attribute | Details |
|-----------|---------|
| **Company** | Altesa Biosciences |
| **Vertical** | B2B Professional Services (Biotech) |
| **Funding** | $75M Series B (Feb 2026) |
| **Location** | US |
| **Buying Signals** | Series B, cardiovascular RNAi therapeutics, clinical trials |
| **Fee Potential** | $5K-$7.5K (Professional Services) |
| **Score Breakdown** | Intent: 28/40, Vertical: 24/30, Size: 14/20, Specificity: 6/10 |
| **Referral Target** | Legal (IP/patents), accounting (R&D credits), clinical consulting |

---

### 8. Poplar Therapeutics — Score: 70/100
| Attribute | Details |
|-----------|---------|
| **Company** | Poplar Therapeutics (fka Phylaxis Bioscience) |
| **Vertical** | B2B Professional Services (Biotech/Immunology) |
| **Funding** | $50M Series A (Jan 2026) |
| **Location** | US |
| **Buying Signals** | Series A, anti-IgE therapies, food allergy pipeline |
| **Fee Potential** | $5K-$7.5K |
| **Score Breakdown** | Intent: 27/40, Vertical: 24/30, Size: 14/20, Specificity: 5/10 |
| **Referral Target** | Legal (FDA compliance), accounting (clinical trials), consulting |

---

### 9. Mysa — Score: 68/100
| Attribute | Details |
|-----------|---------|
| **Company** | Mysa |
| **Vertical** | Financial Services B2B (Fintech) |
| **Funding** | $3.4M Pre-Series A (Feb 2026) |
| **Location** | India |
| **Investors** | Blume Ventures, Piper Serica, QED Innovation Labs |
| **Buying Signals** | Pre-Series A, B2B fintech infrastructure |
| **Fee Potential** | $2.5K |
| **Score Breakdown** | Intent: 26/40, Vertical: 22/30, Size: 12/20, Specificity: 8/10 |
| **Referral Target** | Banking partnerships, compliance, accounting (fintech) |

---

### 10. Tandem — Score: 65/100
| Attribute | Details |
|-----------|---------|
| **Company** | Tandem (withtandem.com) |
| **Vertical** | Technology/SaaS (Healthcare AI) |
| **Funding** | Series B (Feb 2026) |
| **Location** | US |
| **Buying Signals** | Series B, healthcare + AI + B2B software |
| **Fee Potential** | $5K + 10-20% ACV |
| **Score Breakdown** | Intent: 25/40, Vertical: 24/30, Size: 12/20, Specificity: 4/10 |
| **Referral Target** | Healthcare integrations, compliance consulting |

---

## LOWER PRIORITY PROSPECTS (Score <60)

### 11. Validfor — Score: 58/100
| Attribute | Details |
|-----------|---------|
| **Company** | Validfor |
| **Vertical** | Technology/SaaS (Life Sciences) |
| **Funding** | $1.2M (Feb 2026) |
| **CEO** | Omer Cimen |
| **Buying Signals** | AI validation platform, pharma/biotech/medtech focus |
| **Fee Potential** | $5K |
| **Score Breakdown** | Intent: 22/40, Vertical: 20/30, Size: 10/20, Specificity: 6/10 |

---

### 12. Intric — Score: 52/100
| Attribute | Details |
|-----------|---------|
| **Company** | Intric |
| **Vertical** | Technology/SaaS (AI Platform) |
| **Funding** | €3.8M Pre-Seed (Feb 2026) |
| **Location** | Stockholm, Sweden |
| **Lead Investor** | byFounders |
| **Buying Signals** | Sovereign AI platform, European expansion |
| **Fee Potential** | $5K |
| **Score Breakdown** | Intent: 20/40, Vertical: 18/30, Size: 10/20, Specificity: 4/10 |

---

### 13. Mojro — Score: 48/100
| Attribute | Details |
|-----------|---------|
| **Company** | Mojro |
| **Vertical** | Technology/SaaS |
| **Funding** | $3M (Feb 2026) |
| **Investors** | IAN Alpha Fund, 1Crowd |
| **Buying Signals** | B2B SaaS platform, early stage |
| **Fee Potential** | $5K |
| **Score Breakdown** | Intent: 18/40, Vertical: 18/30, Size: 8/20, Specificity: 4/10 |

---

### 14. StepFun — Score: 45/100
| Attribute | Details |
|-----------|---------|
| **Company** | StepFun (stepfun.com) |
| **Vertical** | Technology/SaaS (AI/Data) |
| **Funding** | Series B (Feb 2026) |
| **Location** | China |
| **Buying Signals** | AI + B2B Software + Data + Manufacturing |
| **Fee Potential** | $5K |
| **Score Breakdown** | Intent: 16/40, Vertical: 18/30, Size: 8/20, Specificity: 3/10 |
| **Note** | Lower priority due to China location (US referral focus) |

---

## Vertical Breakdown

| Vertical | Count | Potential Fees |
|----------|-------|----------------|
| Technology/SaaS | 8 | $35,000 - $70,000 |
| Financial Services | 2 | $5,000 |
| Professional Services | 2 | $10,000 - $15,000 |
| Manufacturing | 1 | $1,000 |
| **TOTAL** | **14** | **$46,000 - $87,500** |

---

## Action Items

1. **Immediate Outreach (Today):** Fundamental, Uptiq, Synthpop, Take2
2. **This Week:** ShowroomB2B, Circadian Risk, Altesa, Poplar Therapeutics
3. **Research Phase:** Mysa, Tandem, Validfor

---

## Sources
- TechCrunch AI Funding Report (Feb 2026)
- Growth List Series A/B Databases
- PR Newswire Funding Announcements
- LinkedIn Startup Jobs NYC
- Fintech Futures
- Forbes Fintech 50 (2026)
